 |
|
 |
PCA: 25 Years in the Making: Where Are We Now?
Provided by: ProCE
Upon completion of this activity, pharmacists and nurses will be able to:
* Describe quality improvement models for PCA and the role of nursing and pharmacy in these models
* Discuss pain management in the acute care and ambulatory environment
* Integrate the management of risks associated with PCA use and adequacy of analgesia
* Identify the f... |
 |
Pharmacotherapeutic Management of Chronic Hepatitis C Infection
Provided by: Pharmacy Society of Wisconsin
1. Discuss the current epidemiology and trends of hepatitis C virus (HCV) infection as well as identify key viral transmission modes and their associated risk factors.
2. Describe the natural progression of liver disease associated with HCV and how host, viral, transmission and environmental factors affect disease progression.
3. Discuss the burd... |
 |
HIPAA Security Basics for the Pharmacy Workforce
Provided by: Pharmacy Foundation of California
This course reviews administrative, physical, and technical safeguards mandated by the HIPAA Security requirements; describes required policies and procedures; and introduces the basic concepts of information security.... |
|
Pharmacy Law
Provided by: Pharmacy Society of Wisconsin
Goal: To help pharmacy technicians understand and identify the major legal rules and regulations dealing with the practice of pharmacy.... |
 |
Multiple Sclerosis in Managed Care: Managing Decisions and Shaping Health Outcomes
Provided by: ASiM
Multiple sclerosis (MS) is a costly disease in terms of its effects on patients’ quality of life and its financial cost to society. The introduction of treatments that are designed to change the natural disease course has focused attention on the economic burden of MS. Balancing cost-effective treatment with current guidelines and optimal therapy... |
 |
CPD Toolkit: Strategies for Lifelong Learning in Pharmacy: Health Professionals Inventory of Learning Styles
Provided by: The Collaborative Education Institute
1. Apply principles of learning styles theory to self-reflection
2. Describe methods for identifying personal learning needs/gaps
3. Use the H-PILS as a tool to promote self-reflection... |
|
Managing Drug Interactions with Warfarin
Provided by: The Collaborative Education Institute
Learning Objectives:
Upon successful completion of this program, pharmacists should be able to:
1. Identify factors that contribute to the high prevalence of warfarin drug interactions.
2. Describe the typical time course for warfarin drug interactions.
3. Describe mechanisms for warfarin drug interactions.
4. Discuss various types of drugs or... |
 |
Shifting Paradigms in Type 2 Diabetes: Managed Care Perspectives
Provided by: ASiM
Affecting over 11% of the adult US population, type 2 diabetes mellitus (T2DM) is a chronic and disabling disease that is associated with substantial morbidity from both macro- and microvascular complications. It is the leading cause of kidney failure, nontraumatic lower-limb amputations, and new cases of blindness among American adults, and is a m... |
 |
Managing Chronic Noncancer Pain with Opioids - A Case Approach for the Pharmacists
Provided by: The CE Solution, Inc.
The goal of this activity is to enable pharmacists to apply the latest information about chronic pain management to improve the treatment of patients with chronic noncancer pain requiring use of opioids for an extended duration while minimizing the potential for inappropriate use of the medication.
Accreditation:... |
|
Improving MS Care: Perspectives from a Medical Director, Pharmacy Director, and Specialty Pharmacist
Provided by: ASiM
Multiple sclerosis (MS) is a costly disease in terms of its effects on patients’ quality of life and its financial cost to society. The introduction of treatments that are designed to change the natural disease course has focused attention on the economic burden of MS. Balancing cost-effective treatment with current guidelines and optimal therapy... |
|
MethGuard(TM): Combat Methamphetamine Epidemic Act of 2005
Provided by: Pharmacy Foundation of California
Methamphetamine is being produced in communities across the nation. Small illegal labs use ingredients found in many over-the-counter medicines along with other common household products (legitimate, safe and effective products bought or stolen) to produce this highly addictive drug.
It's an expensive and deadly problem. Not just for those who m... |
|
Mirror Mirror on the Wall: Using Reflection to Enhance Student Learning Activities at Your Practice Site
Provided by: The Collaborative Education Institute
Learning Objectives:
Upon successful completion of this activity, pharmacists should be able to:
1. Explain the role of reflective learning techniques in pharmacy education and continuing professional development (CPD)
2. Compare and contrast action, verbal, and written reflection
3. Cite examples of reflective learning activities designed to e... |
|
Pharmacotherapy in Addiction Treatment
Provided by: Pharmacy Society of Wisconsin
At the conclusion of this activity, the pharmacy technician should be able to:
1. Describe common signs and symptoms associated with chemical dependency.
2. Differentiate among terms relating to addiction such as physical dependence, chemical dependence, and pseudoaddiction.
3. List three drugs used in the management of chemically dependent pati... |
|
Advancing Pharmacy Practice Through Performance Measurement: Future Implications
Provided by: Pharmacy Society of Wisconsin
1. Summarize major recommendations of the Institute of Medicine regarding health care safety and quality.
2. Describe what is meant by "value-driven health care".
3. Describe activities to improve quality in health care and pharmacy practice,including those of the Pharmacy Quality Alliance.
4. Explain the importance of measuring quality in your ... |
 |
Diabetic Neuropathy
Provided by: Ohio Northern University
Description:
Diabetic neuropathy is a heterogeneous disease state in which prevention and therapy must be individualized. Diabetic neuropathy is a complication that will continue to increase in prevalence in the future. As healthcare practitioners, we have a duty to educate patients how to minimize their risk for developing diabetic neuropathy a... |
|
Iowa Pharmacy Law and Information Manual Update
September 2009
Provided by: The Collaborative Education Institute
Learning Objectives:
Upon successful completion of this activity, pharmacists should be able to:
1. Identify changes made to the Iowa Pharmacy Law and Information Manual since April 2009
2. Determine if your pharmacy practice needs to make changes to be in compliance with the
law and/or rule changes
3. Implement changes in the Iowa pharmacy la... |
|
Tapentadol IR: A Gain for Pain?
Provided by: The Collaborative Education Institute
Learning Objectives
1. Describe the mechanism of action of tapentadol immediate release (IR).
2. Determine the appropriate dose and dosing schedule for tapentadol IR.
3. Recognize tapentadol IR's contraindications, warnings and precautions.
4. Identify adverse effects that have been associated with tapentadol IR.
5. Discuss potential drug-drug... |
 |
Spanish Language Training for Pharmacy Professionals
Provided by: RXinsider
Developing Spanish counseling skills will help increase patient compliance and build customer loyalty while setting your pharmacy’s level of customer service apart from competitors. Spanish for Pharmacists is a comprehensive, 52-page book enabling pharmacists and pharmacy technicians to learn the basics of Spanish for effective patient counseling... |
 |
Therapeutic Update 2012
Provided by: University Learning Systems
Session 1 – Diabetes Update: Evidence Based Approaches to the Management of Type 2 Diabetes
Session 2 – Thursday: New Drug Update - Part I
Session 3 – Friday: New Drug Update - Part II
... |
 |
Is it Possible to Significantly Limit or Halt the Damage from Rheumatoid Arthritis (RA)? — The Benefits of Anti-TNF Therapy in Managed Care
Provided by: Impact Education, LLC
TARGET AUDIENCE
This activity has been designed to meet the educational needs of managed care pharmacists, pharmacy directors, medical directors, quality directors, policy executives, managed care affiliated physicians, employer and government policy administrators, and other managed care administrators.
STATEMENT OF NEED
The advent of the ant... |
|
Preceptor Development Core Modules
Provided by: The Collaborative Education Institute
Activity Description:
This knowledge-based continuing pharmacy education activity will equip preceptors with the background information they need to be successful clinical instructors for pharmacy students.... |
 |
Navigating the Management of Chronic Pain:
A Pharmacist's Guide
Provided by: Power-Pak C.E.®
Provide the pharmacist with practical information to support the assessment and management of patients with chronic pain.... |
|
Endemic Mycoses in Wisconsin: An Update on Treatment and the Role of the Pharmacist
Provided by: Pharmacy Society of Wisconsin
To provide an update on the treatment of mycoses endemic to Wisconsin and review Infectious Diseases Society of America.... |
|
How Thick is Too Thick for your Arteries? Ezetimibe vs Niacin for Cardiovascular Risk Reduction?
Provided by: Pharmacy Society of Wisconsin
* Compare second-line lipid lowering agents for special patient populations
* Assess carotid artery media thickness as a clinical endpoint
* Evaluate the primary literature of ezetimibe versus niacin as a guide for therapy management of cardiovascular risk reduction... |
 |
Optimizing Disease Control to Manage RA-Associated Pain in Adults
Provided by: U.S. Pharmacist
After completing this activity, the participant should be able to:
1.Explain the pathophysiology of RA.*
2.Discuss nonbiologic disease-modifying antirheumatic drugs (DMARDs) and biologic DMARD therapies.
3.Identify the potential adverse effects of pharmacologic therapies used for treating pain associated with RA.
4.Evaluate nonpharmacolog... |
|
Continuing Professional Development (CPD) 101
Provided by: The Collaborative Education Institute
Learning Objectives:
Upon successful completion of this activity, pharmacists should be able to:
1. Define Continuing Professional Development (CPD)
2. Describe the need to improve how pharmacists approach their continuing education and
lifelong learning
3. List and describe the components of CPD
4. Apply knowledge to a personal CPD example
... |
|
HIV/AIDS: A Primer for Pharmacists
Provided by: U.S. Pharmacist
This accredited activity is targeted to pharmacists and pharmacy technicians. Estimated time to complete this activity is 120 minutes.
GOAL:
To provide an overview of HIV and AIDS, including clinical features, diagnosis, and treatment strategies.
OBJECTIVES:
After completing this activity, the participant should be able to:
1. Explain th... |
|
Preventing Fraud, Waste & Abuse in Pharmacy Practice -Specialized & CE Exam
Provided by: Pharmacy Foundation of California
This assessment will be used to evaluate your mastery of content provided in Preventing Fraud, Waste & Abuse -2010 Update.... |
|
A Review of Asbestos and Related Consequences
Provided by: U.S. Pharmacist
After completing this activity, participants should be able to:
1. Discuss the origin of asbestos and its impact on health.*
2. Identify the risk factors and etiology of asbestos-related diseases.*
3. Differentiate between various asbestos-related diseases.*
4. Provide information on the current regulation of asbestos.*
5. Recognize... |
 |
Building the bridge to partnership: Fostering the community and managed care pharmacy relationship
Provided by: Academy of Managed Care Pharmacy
Description:
Discover how managed care organizations and community pharmacists are working together to help advance medication therapy management services.... |
|
|
Virtual Exhibits / Booths
Join Email List
Visit Our Website
View Literature
